Monday, October 30, 2017 10:15 PM ET
Insider at VBI Vaccines (VBIV) Makes Significant purchase of Stock Extends the Trend of Last Quarter
Notable insider buying activity was revealed in VBI Vaccines shares in a form 4 document filed with the SEC today, showing — Perceptive Advisors Llc, 10% Owner — acquired 3,100,000 shares in the company having a net market value of approximately $9,455,000. There have been 2 insiders with buy/sell transactions in the past 90 days prior to this filing. All of these trades have been buys resulting in the purchase of 23,000 company shares. Adding the most recent activity to this 90-day history indicates insider trades have seen net purchases of 3,123,000 shares and have averaged 1,041,000 shares per transaction over this time period.
Over the last 90 days, the number of insider buy/sell trades at VBI Vaccines is greater than the 184-company peer group average. Biotechnology & Medical Research peer group saw 208 buy/sell trades during this period for an average of 1.1 transactions per company. The number of shares per buy/sell trade for VBI Vaccines insiders was also higher. Within the peer group there were 7,794,256 shares purchased and 51,306,345 shares sold with company insiders disposing of 209,193 shares on average.
In order to focus on significant insider buying and selling activity, all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers has been eliminated data obtained to evaluate and write this story.
Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at firstname.lastname@example.org. Copyright 2017 UpTick Data Technologies. All rights reserved.